| Appearance | Creamish to white powder |
| Purity / Analysis Method | 99.67% (HPLC) |
| Los on drying | NMT 0.5% |
| Water | NMT 4.5 – 6.0% |
| Sulphated Ash | NMT 0.2% |
| Solubility | Soluble in Water |
Teneligliptin Hbr.
Teneligliptin (hydrobromide hydrate); 3-[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine, hydrobromide, hydrate, [(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]-3-thiazolidinylmethanone, hydrobromide (1:x), hydrate (1:x), [(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-yl](1,3-thiazolidin-3-yl)methanone, hydrobromide, hydrate;
| Purity / Analysis Method | 98.0% – 102.0% (HPLC) |
| Molecular Formula / Molecular Weight | C22H30N6OS · 2.5HBr · yH2O = 426.6 |
| Physical State (20 deg.C) | Solid |
| CAS RN | 1572583-29-9 |
| Unit | Price |
| 1 g | 7500 |
| 5 g | 17000 |
| 10 g | 25500 |
| Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
|---|




